AT258984T - compositions bmp 11 - Google Patents

compositions bmp 11

Info

Publication number
AT258984T
AT258984T AT94917361T AT94917361T AT258984T AT 258984 T AT258984 T AT 258984T AT 94917361 T AT94917361 T AT 94917361T AT 94917361 T AT94917361 T AT 94917361T AT 258984 T AT258984 T AT 258984T
Authority
AT
Austria
Prior art keywords
bmp
compositions
Prior art date
Application number
AT94917361T
Other languages
German (de)
Inventor
Anthony J Celeste
John M Wozney
Original Assignee
Inst Genetics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US6146493A priority Critical
Application filed by Inst Genetics Llc filed Critical Inst Genetics Llc
Priority to PCT/US1994/005288 priority patent/WO1994026892A1/en
Publication of AT258984T publication Critical patent/AT258984T/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • A61K38/1875Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/51Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602Vertebrate cells
    • C12N5/0618Cells of the nervous system
    • C12N5/0619Neurons
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/155Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/12Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides
AT94917361T 1993-05-12 1994-05-12 compositions bmp 11 AT258984T (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US6146493A true 1993-05-12 1993-05-12
PCT/US1994/005288 WO1994026892A1 (en) 1993-05-12 1994-05-12 Bmp-11 compositions

Publications (1)

Publication Number Publication Date
AT258984T true AT258984T (en) 2004-02-15

Family

ID=22035966

Family Applications (2)

Application Number Title Priority Date Filing Date
AT03021107T AT343635T (en) 1993-05-12 1994-05-12 Bmp-11 compositions
AT94917361T AT258984T (en) 1993-05-12 1994-05-12 compositions bmp 11

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT03021107T AT343635T (en) 1993-05-12 1994-05-12 Bmp-11 compositions

Country Status (17)

Country Link
US (7) US5639638A (en)
EP (4) EP0698094B1 (en)
JP (2) JP3681069B2 (en)
KR (1) KR100227406B1 (en)
AT (2) AT343635T (en)
AU (1) AU678582B2 (en)
BR (1) BR9406715A (en)
CA (1) CA2161808C (en)
DE (4) DE69433530T2 (en)
DK (2) DK1378572T3 (en)
ES (2) ES2213745T3 (en)
FI (1) FI119696B (en)
HK (1) HK1060898A1 (en)
NO (1) NO320119B1 (en)
OA (1) OA10191A (en)
PT (2) PT698094E (en)
WO (1) WO1994026892A1 (en)

Families Citing this family (126)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6150328A (en) * 1986-07-01 2000-11-21 Genetics Institute, Inc. BMP products
JP3504263B2 (en) 1991-11-04 2004-03-08 ジェネティックス・インスチチュート・リミテッド・ライアビリティ・カンパニー Recombinant bone morphogenic protein heterodimer, compositions and use
US20080139474A1 (en) * 1991-11-04 2008-06-12 David Israel Recombinant bone morphogenetic protein heterodimers, compositions and methods of use
US20030074680A1 (en) * 1993-03-19 2003-04-17 Johns Hopkins University School Of Medicine Growth differentiation factor-8
US6465239B1 (en) * 1993-03-19 2002-10-15 The John Hopkins University School Of Medicine Growth differentiation factor-8 nucleic acid and polypeptides from aquatic species and non-human transgenic aquatic species
US7332575B2 (en) * 1994-03-18 2008-02-19 The Johns Hopkins University School Of Medicine Growth differentiation factor-8 nucleic acid and polypeptide from aquatic species, and transgenic aquatic species
US7393682B1 (en) * 1993-03-19 2008-07-01 The Johns Hopkins University School Of Medicine Polynucleotides encoding promyostatin polypeptides
EP0698094B1 (en) * 1993-05-12 2004-02-04 Genetics Institute, LLC Bmp-11 compositions
US6291206B1 (en) * 1993-09-17 2001-09-18 Genetics Institute, Inc. BMP receptor proteins
ES2255059T3 (en) * 1993-12-07 2006-06-16 Genetics Institute, Llc Bmp-12, bmp-13 and your induction compositions of tendon.
US5942496A (en) 1994-02-18 1999-08-24 The Regent Of The University Of Michigan Methods and compositions for multiple gene transfer into bone cells
US6551618B2 (en) 1994-03-15 2003-04-22 University Of Birmingham Compositions and methods for delivery of agents for neuronal regeneration and survival
US5906827A (en) 1994-06-03 1999-05-25 Creative Biomolecules, Inc. Matrix for the manufacture of autogenous replacement body parts
US6008434A (en) 1994-07-08 1999-12-28 Johns Hopkins University School Of Medicine Growth differentiation factor-11 transgenic mice
DE69534468T2 (en) * 1994-07-08 2006-07-13 The Johns Hopkins University School Of Medicine Growth differentiation factor 11
US20030167492A1 (en) * 1994-07-08 2003-09-04 Johns Hopkins University School Of Medicine Transgenic non-human animals expressing a gdf-11 dominant negative polypeptide, and methods of making and using same
US5846770A (en) * 1994-11-22 1998-12-08 Genetics Institute, Inc. DNA molecules encoding human chordin
US5635372A (en) * 1995-05-18 1997-06-03 Genetics Institute, Inc. BMP-15 compositions
HU222664B1 (en) 1995-06-05 2003-09-29 Genetics Institute, Llc Bone morphogenetic protein (BMP), bone and tendon or ligament regeneration of a functional connection of the application
US5902785A (en) * 1995-06-06 1999-05-11 Genetics Institute, Inc. Cartilage induction by bone morphogenetic proteins
US5645084A (en) * 1995-06-07 1997-07-08 Danek Medical, Inc. Method for spinal fusion without decortication
US5700774A (en) * 1996-03-26 1997-12-23 Genetics Institute, Inc. Compositions comprising bone morphogenic proteins and truncated parathyroid hormone related peptide, and methods of inducing cartilage by administration of same
US5965403A (en) 1996-09-18 1999-10-12 Genetics Institute, Inc. Nucleic acids encoding bone morphogenic protein-16 (BMP-16)
EP0973926A1 (en) * 1997-03-14 2000-01-26 Selective Genetics, Inc. Adenoviral vectors with modified tropism
US7041641B2 (en) 1997-03-20 2006-05-09 Stryker Corporation Osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects
JP2001526788A (en) 1997-05-30 2001-12-18 クリエイティブ バイオモレキュールズ,インコーポレイテッド Methods for assessing tissue morphogenesis and activity
US7147839B2 (en) 1998-05-29 2006-12-12 Curis, Inc. Methods for evaluating tissue morphogenesis and activity
US5972368A (en) 1997-06-11 1999-10-26 Sdgi Holdings, Inc. Bone graft composites and spacers
US7923250B2 (en) 1997-07-30 2011-04-12 Warsaw Orthopedic, Inc. Methods of expressing LIM mineralization protein in non-osseous cells
EP1007673B1 (en) 1997-07-30 2008-12-17 Emory University Novel bone mineralization proteins, dna, vectors, expression systems
US6696260B1 (en) * 1997-08-01 2004-02-24 The Johns Hopkins University School Of Medicine Methods to identify growth differentiation factor (GDF) binding proteins
WO1999006559A1 (en) * 1997-08-01 1999-02-11 The Johns Hopkins University School Of Medicine Methods to identify growth differentiation factor (gdf) receptors
US6891082B2 (en) * 1997-08-01 2005-05-10 The Johns Hopkins University School Of Medicine Transgenic non-human animals expressing a truncated activintype II receptor
US20020052026A1 (en) 1997-10-08 2002-05-02 Steven M. Vicik Methods of refolding proteins
US6511509B1 (en) 1997-10-20 2003-01-28 Lifenet Textured bone allograft, method of making and using same
US6037519A (en) 1997-10-20 2000-03-14 Sdgi Holdings, Inc. Ceramic fusion implants and compositions
WO1999024057A2 (en) * 1997-11-07 1999-05-20 Genetics Inst Neuronal uses of bmp-11
US6027917A (en) * 1997-12-10 2000-02-22 Genetics Institute, Inc. Bone morphogenetic protein (BMP)-17 and BMP-18 compositions
US20030036629A1 (en) * 1997-12-12 2003-02-20 Barry Foster Novel tgf-beta protein purification methods
US6004937A (en) * 1998-03-09 1999-12-21 Genetics Institute, Inc. Use of follistatin to modulate growth and differentiation factor 8 [GDF-8] and bone morphogenic protein 11 [BMP-11]
US20010016646A1 (en) 1998-03-20 2001-08-23 David C. Rueger Osteogenic devices and methods of use thereof for repair of endochondral bone, osteochondral and chondral defects
BR9912548A (en) * 1998-07-28 2002-01-29 Univ Johns Hopkins Med Factor-11 growth differentiation
EP1102568A1 (en) 1998-08-06 2001-05-30 SDGI Holdings, Inc. Composited intervertebral bone spacers
US6849255B2 (en) * 1998-08-18 2005-02-01 Yissum Research Development Company Of The Hebrew University Of Jerusalem Methods and compositions for enhancing cartilage repair
US6727224B1 (en) * 1999-02-01 2004-04-27 Genetics Institute, Llc. Methods and compositions for healing and repair of articular cartilage
CA2371695A1 (en) * 1999-04-30 2000-11-09 Curis, Inc. Morphogen-induced enhancement of fertility
EP1244388B1 (en) 1999-12-06 2007-01-17 Warsaw Orthopedic, Inc. Intervertebral disc treatment device
DE20004692U1 (en) 2000-03-14 2001-07-26 Sofamor Danek Gmbh Implant to be screwed into an intervertebral space
US20030082233A1 (en) * 2000-12-01 2003-05-01 Lyons Karen M. Method and composition for modulating bone growth
US6752831B2 (en) 2000-12-08 2004-06-22 Osteotech, Inc. Biocompatible osteogenic band for repair of spinal disorders
DE60138643D1 (en) 2000-12-08 2009-06-18 Osteotech Inc Implant for orthopedic applications
US7141392B2 (en) 2001-01-09 2006-11-28 Queen Mary And Westfield College Latent fusion protein
GB0100551D0 (en) 2001-01-09 2001-02-21 Queen Mary & Westfield College Protein
TW200526779A (en) 2001-02-08 2005-08-16 Wyeth Corp Modified and stabilized GDF propeptides and uses thereof
EP1790726B1 (en) * 2001-02-08 2013-07-03 Wyeth LLC Modified and stabilized GDF propeptides and uses thereof
KR100420798B1 (en) * 2001-02-10 2004-03-02 (주)알에이싸이언스 Peptide vector
EP1399023B1 (en) * 2001-06-01 2008-04-30 Wyeth COMPOSITIONS FOR SYSTEMIC ADMINISTRATION OF SEQUENCES ENCODING BONE MORPHOGENETIC PROTEINS& x9;
TWI267378B (en) 2001-06-08 2006-12-01 Wyeth Corp Calcium phosphate delivery vehicles for osteoinductive proteins
US7320789B2 (en) 2001-09-26 2008-01-22 Wyeth Antibody inhibitors of GDF-8 and uses thereof
US6798160B2 (en) * 2001-11-02 2004-09-28 Honda Giken Kogyo Kabushiki Kaisha Electric working machine
CA2467260C (en) * 2001-11-27 2010-07-06 Takiron Co., Ltd. A porous organic-inorganic composite implant material and process for producing the same
CH695985A5 (en) * 2002-01-21 2006-11-15 Straumann Holding Ag Surface-modified implants.
PL375045A1 (en) 2002-02-21 2005-11-14 Wyeth Gasp1: a follistatin domain containing protein
AU2003216345A1 (en) * 2002-02-21 2003-09-09 Wyeth Follistatin domain containing proteins
CN1665525A (en) * 2002-05-17 2005-09-07 惠氏公司 Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins
CN1735426A (en) 2002-08-13 2006-02-15 惠氏公司 Peptides as solubilizing excipients for transforming growth factor ss proteins
EP1549747A4 (en) * 2002-09-16 2006-08-23 Wyeth Corp Metalloprotease activation of myostatin, and methods of modulating myostatin activity
AR047392A1 (en) 2002-10-22 2006-01-18 Wyeth Corp Neutralizing antibodies against GDF 8 and their use for such purposes
US20040223966A1 (en) * 2002-10-25 2004-11-11 Wolfman Neil M. ActRIIB fusion polypeptides and uses therefor
AU2004245025A1 (en) 2003-06-02 2004-12-16 Wyeth Use of myostatin (GDF8) inhibitors in conjunction with corticosteroids for treating neuromuscular disorders
BRPI0413720A (en) * 2003-09-12 2006-10-17 Wyeth Corp injectable calcium phosphate sticks and solid pastes for release of osteogenic proteins
AT478008T (en) 2004-03-10 2010-09-15 Scil Technology Gmbh Coated implants, their manufacture and use thereof
AU2005247871A1 (en) 2004-04-27 2005-12-08 Research Development Foundation Antagonism of TGF-beta superfamily receptor signaling
EP2298335B1 (en) 2004-05-25 2014-09-03 Stryker Corporation Use of OP-1 for treating cartilage defects
US7749268B2 (en) 2004-05-26 2010-07-06 Warsaw Orthopedic, Inc. Methods for treating the spine
CN101001642A (en) * 2004-08-12 2007-07-18 惠氏公司 Combination therapy for diabetes, obesity, and cardiovascular diseases using GDF-8 inhibitors
US9161967B2 (en) 2006-06-30 2015-10-20 Biomimetic Therapeutics, Llc Compositions and methods for treating the vertebral column
US7473678B2 (en) 2004-10-14 2009-01-06 Biomimetic Therapeutics, Inc. Platelet-derived growth factor compositions and methods of use thereof
WO2006081379A1 (en) * 2005-01-26 2006-08-03 Wyeth Use of sfrps as markers of bmp activity
EP1864139A2 (en) * 2005-03-23 2007-12-12 Wyeth Detection of an immune response to gdf-8 modulating agents
MX2007011591A (en) * 2005-03-30 2007-12-10 Wyeth Corp Methods for stimulating hair growth by administering bmps.
US8506646B2 (en) 2005-04-29 2013-08-13 Warsaw Orthopedic, Inc. Multi-purpose medical implant devices
US20060247790A1 (en) * 2005-04-30 2006-11-02 Mckay William F Shaped osteochondral grafts and methods of using same
AU2006302494B2 (en) 2005-10-06 2011-01-06 Eli Lilly And Company Anti-myostatin antibodies
BRPI0617345A2 (en) 2005-10-12 2011-07-26 Lilly Co Eli monoclonal antibody antimiostatin, pharmaceutical composition, and its use
US8147860B2 (en) 2005-12-06 2012-04-03 Etex Corporation Porous calcium phosphate bone material
EP1991282B1 (en) 2006-02-09 2013-06-19 BioMimetic Therapeutics, LLC Compositions and methods for treating bone
AU2007257208B2 (en) 2006-05-17 2013-05-02 Stryker Corporation Use of a soluble morphogenic protein complex for treating cartilage defects
AU2007269712B2 (en) 2006-06-30 2013-02-07 Biomimetic Therapeutics, Llc PDGF-biomatrix compositions and methods for treating rotator cuff injuries
US8524265B2 (en) 2006-08-17 2013-09-03 Warsaw Orthopedic, Inc. Medical implant sheets useful for tissue regeneration
ES2404941T3 (en) 2006-09-05 2013-05-29 Eli Lilly And Company anti-myostatin antibodies
JP2008104401A (en) * 2006-10-25 2008-05-08 Kyoto Univ In-vitro proliferation method of spermatogonial stem cell
AU2007234612B2 (en) 2006-12-14 2013-06-27 Johnson & Johnson Regenerative Therapeutics, Llc Protein stabilization formulations
JP5452230B2 (en) 2006-12-21 2014-03-26 ストライカー コーポレイションStryker Corporation Sustained release formulations comprising biological agent crystals, polymer gels and particle suspensions
US7678764B2 (en) 2007-06-29 2010-03-16 Johnson & Johnson Regenerative Therapeutics, Llc Protein formulations for use at elevated temperatures
CA2695697A1 (en) 2007-08-07 2009-02-12 Advanced Technologies And Regenerative Medicine, Llc Protein formulations comprising gdf-5 in aqueous acidic solution
US8741840B2 (en) 2008-02-13 2014-06-03 Washington University BMP-7 for use in treating neointimal hyperplasia
CN102026619A (en) 2008-04-14 2011-04-20 先进科技及再生医学有限责任公司 Liquid buffered GDF-5 formulations
JP5816553B2 (en) 2008-09-09 2015-11-18 バイオミメティック セラピューティクス, エルエルシー Platelet-derived growth factor compositions and methods for treating tendon or ligament injury
JP5819733B2 (en) 2009-02-12 2015-11-24 ストライカー コーポレイションStryker Corporation Peripheral administration of TGF-β superfamily member-containing protein for systemic treatment of disorders and diseases
US20100204124A1 (en) 2009-02-12 2010-08-12 Mary Elizabeth Pecquet Goad Compositions and Methods for Minimally-Invasive Systemic Delivery of Proteins Including TGF-Beta Superfamily Members
US20120148539A1 (en) 2009-03-24 2012-06-14 Moulay Hicham Alaoui-Ismaili Methods and Compositions for Tissue Engineering
US8609127B2 (en) 2009-04-03 2013-12-17 Warsaw Orthopedic, Inc. Medical implant with bioactive material and method of making the medical implant
US20110002897A1 (en) 2009-06-11 2011-01-06 Burnham Institute For Medical Research Directed differentiation of stem cells
US9399086B2 (en) 2009-07-24 2016-07-26 Warsaw Orthopedic, Inc Implantable medical devices
WO2011031856A1 (en) 2009-09-09 2011-03-17 Stryker Corporation Bmp -7 for use in treating pain induced by injuries and diseases of an articular joint
EP2352750B1 (en) 2009-09-17 2012-06-13 Stryker Corporation Buffers for controlling the ph of bone morphogenetic proteins
JP2013514811A (en) 2009-12-22 2013-05-02 ストライカー コーポレイションStryker Corporation BMP-7 mutant with reduced immunogenicity
WO2011139594A2 (en) 2010-04-27 2011-11-10 Medtronic, Inc. Artificial bursa for intra-articular drug delivery
PE01352014A1 (en) 2010-08-20 2014-02-20 Wyeth Llc Designing osteogenic protein
US9688735B2 (en) 2010-08-20 2017-06-27 Wyeth Llc Designer osteogenic proteins
US8998925B2 (en) 2011-06-20 2015-04-07 Rdc Holdings, Llc Fixation system for orthopedic devices
WO2012177759A1 (en) 2011-06-20 2012-12-27 Rdc Holdings, Llc System and method for repairing joints
CA2901394A1 (en) * 2012-03-19 2013-09-26 The Brigham And Women's Hosptial, Inc. Growth differentiation factor (gdf) for treatment of diastolic heart failure
US10034945B2 (en) 2012-07-13 2018-07-31 Trustees Of Tufts College Silk powder compaction for production of constructs with high mechanical strength and stiffness
US20160120945A1 (en) * 2013-02-15 2016-05-05 The Brigham And Women's Hospital, Inc. Thymic Regeneration
JP2016518357A (en) * 2013-04-08 2016-06-23 プレジデント アンド フェローズ オブ ハーバード カレッジ Methods and compositions for rejuvenating skeletal muscle stem cells
AU2014253753B2 (en) 2013-04-19 2017-03-30 Theracell, Inc. Demineralized bone fibers having controlled geometry and shapes and methods thereof
WO2015070076A2 (en) * 2013-11-08 2015-05-14 President And Fellows Of Harvard College Methods and compositions for rejuvenating neuromuscular junctions
WO2015073396A1 (en) 2013-11-12 2015-05-21 The Brigham And Women's Hospital, Inc. Growth differentiation factor (gdf) for treatment of diastolic heart failure
US10428130B2 (en) 2015-03-17 2019-10-01 Istituto Biochimico Italiano Giovanni Lorenzini S.P.A. Purification of bone morphogenetic proteins (BMPs)
KR101810385B1 (en) * 2016-02-04 2017-12-20 주식회사 강스템바이오텍 Composition comprising GDF11 and uses thereof
US20180140746A1 (en) 2016-11-21 2018-05-24 Warsaw Orthopedic, Inc. Lyophilized moldable implants containing an oxysterol
US20180353654A1 (en) 2017-06-12 2018-12-13 Warsaw Orthopedic, Inc. Moldable formulations containing an oxysterol in an acellular tissue matrix
KR101893339B1 (en) * 2017-09-19 2018-08-31 주식회사 강스템바이오텍 Composition comprising GDF11 and uses thereof
US20190255216A1 (en) 2018-02-22 2019-08-22 Warsaw Orthopedic, Inc. Demineralized bone matrix having improved handling characteristics

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4419446A (en) 1980-12-31 1983-12-06 The United States Of America As Represented By The Department Of Health And Human Services Recombinant DNA process utilizing a papilloma virus DNA as a vector
DE3382562D1 (en) 1982-09-24 1992-06-25 Us Health Restoration of tissue in animals.
US4588684A (en) 1983-04-26 1986-05-13 Chiron Corporation a-Factor and its processing signals
NZ210699A (en) 1984-01-04 1989-06-28 Int Genetic Eng Isolation of an osteogenic protein of the p3 immunologically related family
ZA8408495B (en) 1984-01-31 1985-09-25 Idaho Res Found Production of polypeptides in insect cells
CA1341617C (en) 1984-06-08 2011-06-28 Henry George Burger Inhibin isolated from ovarian follicular fluid
JP2540509B2 (en) 1984-07-06 1996-10-02 サンド・アクチエンゲゼルシヤフト Production and purification of lymphokines
AT128715T (en) 1984-07-16 1995-10-15 Celtrix Pharma Polypeptides inducing factors in bone and cartilage.
DE3586386D1 (en) 1984-10-05 1992-08-27 Genentech Inc Dna, cell cultures and methods for secretion of heterologous proteins and periplasmic proteinrueckgewinnung.
US4740587A (en) * 1985-07-18 1988-04-26 The Salk Institute For Biological Studies Inhibin and method of purifying same
NZ217727A (en) * 1985-10-03 1990-05-28 Genentech Inc Nucleic acid encoding alpha or b chain of inhibin, its production and compositions containing it
US5089396A (en) * 1985-10-03 1992-02-18 Genentech, Inc. Nucleic acid encoding β chain prodomains of inhibin and method for synthesizing polypeptides using such nucleic acid
US5215893A (en) * 1985-10-03 1993-06-01 Genentech, Inc. Nucleic acid encoding the ba chain prodomains of inhibin and method for synthesizing polypeptides using such nucleic acid
US4798885A (en) 1986-02-07 1989-01-17 Genentech, Inc. Compositions of hormonally active human and porcine inhibin containing an α chain and 62 chain
US4737578A (en) * 1986-02-10 1988-04-12 The Salk Institute For Biological Studies Human inhibin
US5106748A (en) 1986-07-01 1992-04-21 Genetics Institute, Inc. Dna sequences encoding 5 proteins
ZA8704681B (en) 1986-07-01 1988-04-27 Genetics Inst Novel osteoinductive factors
US5108922A (en) 1986-07-01 1992-04-28 Genetics Institute, Inc. DNA sequences encoding BMP-1 products
IL83003A (en) * 1986-07-01 1995-07-31 Genetics Inst Osteoinductive factors
US5013649A (en) * 1986-07-01 1991-05-07 Genetics Institute, Inc. DNA sequences encoding osteoinductive products
US5187076A (en) * 1986-07-01 1993-02-16 Genetics Institute, Inc. DNA sequences encoding BMP-6 proteins
US5041538A (en) * 1987-08-28 1991-08-20 The Salk Institute For Biological Studies Mammalian follistatin
US5168150A (en) 1988-03-17 1992-12-01 Electronique Serge Dassault Device for the processing of a magnetic-track ticket, especially an air transport ticket
US5071834A (en) 1988-09-16 1991-12-10 Genentech, Inc. Purified activin B composition
US5166190A (en) * 1990-01-08 1992-11-24 Genentech, Inc. Method for increasing fertility in males
DE69132823T2 (en) * 1990-05-16 2002-07-18 Genetics Inst Bone and cartilage formation-inducing proteins
US5168050A (en) * 1990-05-24 1992-12-01 Genentech, Inc. Mammalian expression of the bone morphogenetic protein-2b using bmp2a/bmp2b fusion
AT253589T (en) * 1990-09-26 2003-11-15 Inst Genetics Llc Bmp-5 derivatives
EP0513334A4 (en) * 1990-11-30 1993-08-04 Celtrix Laboratories, Inc. Use of a bone morphogenetic protein in synergistic combination with tgf--g(b) for bone repair
US5208219A (en) 1991-02-14 1993-05-04 Celtrix Pharmaceuticals Inc. Method for inducing bone growth
JPH07500315A (en) * 1991-05-10 1995-01-12
CA2108770C (en) * 1991-06-25 2007-04-03 John M. Wozney Bmp-9 compositions
US5171579A (en) * 1991-10-11 1992-12-15 Genetics Institute, Inc. Formulations of blood clot-polymer matrix for delivery of osteogenic proteins
JP3504263B2 (en) * 1991-11-04 2004-03-08 ジェネティックス・インスチチュート・リミテッド・ライアビリティ・カンパニー Recombinant bone morphogenic protein heterodimer, compositions and use
WO1994003200A1 (en) 1992-07-31 1994-02-17 Creative Biomolecules, Inc. Morphogen-induced nerve regeneration and repair
DE69432815T2 (en) * 1993-03-19 2003-12-11 Univ Johns Hopkins Med Growth factor-8
EP0698094B1 (en) * 1993-05-12 2004-02-04 Genetics Institute, LLC Bmp-11 compositions
DE69433742D1 (en) * 1993-05-12 2004-06-03 Inst Genetics Llc compositions bmp 10
AT326234T (en) * 1993-08-26 2006-06-15 Genetics Inst Llc Human bone morphogenetic proteins for use in neuronal regeneration
DE69534468T2 (en) * 1994-07-08 2006-07-13 The Johns Hopkins University School Of Medicine Growth differentiation factor 11
US5545616A (en) * 1994-09-22 1996-08-13 Genentech, Inc. Method for predicting and/or preventing preterm labor
EP0894004B2 (en) 1996-03-22 2007-02-21 Curis, Inc. Method for enhancing functional recovery of motor coordination, speech or sensory perception after central nervous system ischemia or trauma
JP3361278B2 (en) 1997-12-26 2003-01-07 シャープ株式会社 Reflection type liquid crystal display device and manufacturing method thereof, and manufacturing method of the circuit board
US6004937A (en) * 1998-03-09 1999-12-21 Genetics Institute, Inc. Use of follistatin to modulate growth and differentiation factor 8 [GDF-8] and bone morphogenic protein 11 [BMP-11]

Also Published As

Publication number Publication date
JP2005046155A (en) 2005-02-24
US6437111B1 (en) 2002-08-20
CA2161808A1 (en) 1994-11-24
FI955419D0 (en)
PT1378572E (en) 2007-01-31
AU678582B2 (en) 1997-06-05
US5639638A (en) 1997-06-17
NO954492D0 (en) 1995-11-08
US5700911A (en) 1997-12-23
WO1994026892A1 (en) 1994-11-24
EP0698094A1 (en) 1996-02-28
ES2213745T3 (en) 2004-09-01
EP1378572A1 (en) 2004-01-07
DK0698094T3 (en) 2004-05-03
DE69434875D1 (en) 2006-12-07
EP1770161A3 (en) 2008-04-23
NO320119B1 (en) 2005-10-31
FI119696B (en) 2009-02-13
FI119696B1 (en)
JP3681069B2 (en) 2005-08-10
BR9406715A (en) 1996-02-06
DK698094T3 (en)
US6340668B1 (en) 2002-01-22
KR100227406B1 (en) 1999-12-01
DE69433530D1 (en) 2004-03-11
OA10191A (en) 1996-12-18
DE69434875T2 (en) 2007-09-06
PT698094E (en) 2004-05-31
EP1770161A2 (en) 2007-04-04
NO954492L (en) 1995-11-08
HK1060898A1 (en) 2006-12-29
JPH09501304A (en) 1997-02-10
FI955419A (en) 1996-01-08
DE69433530T2 (en) 2005-01-05
ES2274157T3 (en) 2007-05-16
EP2272959A1 (en) 2011-01-12
KR960701996A (en) 1996-03-28
EP0698094B1 (en) 2004-02-04
DK1378572T3 (en) 2007-02-05
US20030166910A1 (en) 2003-09-04
FI955419A0 (en) 1995-11-10
CA2161808C (en) 2008-08-05
US20060172391A1 (en) 2006-08-03
US7175997B2 (en) 2007-02-13
AU6910594A (en) 1994-12-12
AT343635T (en) 2006-11-15
EP1378572B1 (en) 2006-10-25
US20030083252A1 (en) 2003-05-01

Similar Documents

Publication Publication Date Title
DK0725788T3 (en) 2'-amido or 2'-peptidomodificerede oligonucleotides
DE69322946T2 (en) Photoresist composition
DE69326184T2 (en) Radiation-sensitive compositions
DE69326913T2 (en) Leichtdispergierbare polydextrose compositions comprising
DE69408985T2 (en) atomizer
DE69312531D1 (en) cleaning composition
DE69418305D1 (en) Compositions and uses thereof
DE69332529T2 (en) encryptor
DE69227390D1 (en) ink compositions
DE69409873D1 (en) dentures
DE69230645D1 (en) implant
DE69430628D1 (en) Microemulsion and emulsion-cleansing compositions
AT179166T (en) N'-substituted-n-insecticidal n'diacylhydrazin
DK1142893T3 (en) Substituted 6 (4) -benzyloxypyrimidiner
DE69301999D1 (en) Photoresist composition
NO944980D0 (en) immunoconjugates
DE69615208T2 (en) refreshing compositions
DE69434258D1 (en) Microencapsulated 1,2-benzazoles
DE69232419T2 (en) Radiation-curable compositions cyclobutarene
DE69306808D1 (en) Auxiliary or ergänzungsorthese the knee
DE69406649D1 (en) N-alkyl-2-substituted ATP analogue
DE69229806T2 (en) Detergent composition
DE69406272T2 (en) Feuchttigkeitsbeständige composition
DE69302465D1 (en) paintbox
DE69302360D1 (en) N-oxycarbonyl substitutierte 5'-deoxy-5-Fluorocytidin

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0698094

Country of ref document: EP